Clinical Trial Details
Trial ID: | L0027 |
Source ID: | NCT01373554 |
Associated Drug: | Oltipraz |
Title: | Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease |
Acronym: | PMK-N01GI1 |
Status: | Completed |
Study Results: | No Results Available |
Results: | -- |
Conditions: | Non-alcoholic Fatty Liver Disease |
Interventions: | Drug: Placebo|Drug: Oltipraz |
Outcome Measures: | MRS|change in ALT, AST and total bilirubin|change in Cholesterol, Triglyceride|change in HOMA-IR|change in BMI|changes in NAS |
Sponsor/Collaborators: | PharmaKing |
Gender: | All |
Age: | 18 Years to 75 Years ?? (Adult, Older Adult) |
Phases: | Phase 2 |
Enrollment: | 60 |
Study Type: | Interventional |
Study Designs: | Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment |
Start Date: | May 2011 |
Completion Date: | October 2013 |
Results First Posted: | -- |
Last Update Posted: | December 10, 2013 |
Locations: | Inje University Ilsan Paik Hospital, Dahwa-dong, Ilsanseo-gu, Goyang-si, Gyeonggi-do, Korea, Republic of|NHUS Ilsan Hospital, Ilsan-ro Ilsan-donggu, Goyang-si, Korea, Republic of|Seoul National University Hospital, Daehak-ro Jongno-gu, Seoul, Korea, Republic of|Korea University Guro hospital, Gurodong-ro, Seoul, Korea, Republic of|Boramae Hospital, Sindaebang-dong Dongjak-gu, Seoul, Korea, Republic of |
URL: | https://ClinicalTrials.gov/show/NCT01373554 |